✦ LIBER ✦

Serotonergic drugs in the treatment of depressive and anxiety disorders

✍ Scribed by Johan A. Den Boer; Fokko J. Bosker; Bernhard R. Slaap

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 151 KB
Volume: 15
Category: Article
ISSN: 0885-6222
DOI: 10.1002/1099-1077(200007)15:5<315::aid-hup204>3.0.co;2-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of serotonergic and noradrenergic s

Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders

✍ Kerry J. Ressler; Charles B. Nemeroff 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

There is abundant evidence for abnormalities of the norepinephrine (NE) and serotonin (5HT) neurotransmitter systems in depression and anxiety disorders. The majority of evidence supports underactivation of serotonergic function and complex dysregulation of noradrenergic function, most consistent wi

Sertraline in the treatment of anxiety d

Sertraline in the treatment of anxiety disorders

✍ Robert M.A. Hirschfeld 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 1 views

Controlled Comparison of Tianeptine, Alp

Controlled Comparison of Tianeptine, Alprazolam and Mianserin in the Treatment of Adjustment Disorders with Anxiety and Depression

✍ MARC ANSSEAU; MICHEL BATAILLE; GUY BRIOLE; ANDRÉ DE NAYER; PIERRE ANDRÉ FAUCHÈRE 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 439 KB 👁 1 views

A multicentre study compared tianeptine (37.5 mg/day), an original psychotropic compound characterized by both antidepressant and anxiolytic potentials, with a reference antidepressant, mianserin (60 mgkday) and a reference anxiolytic, alprazolam (1.5 mglday), in the treatment of 152 patients fulfil

Assessment of locus of control in patien

Assessment of locus of control in patients with anxiety and depressive disorders

✍ Barbara L. Kennedy; Gregory V. Lynch; John J. Schwab 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

We studied Levenson's Internal (I), Powerful Others (P), and Chance (C) locus of control scales in 193 patients with six DSM-III-R diagnoses: Major Depression (MD), Panic Disorder (PD), Generalized Anxiety Disorder (GAD), Social Phobia (SP), Obsessive Compulsive Disorder (OCD), and Mixed Anxiety Dep

The doctor-patient relationship in pharm

The doctor-patient relationship in pharmacotherapy. Improving treatment effectiveness ; Treatment plans and interventions for depression and anxiety disorders

✍ Luis F. Ramirez 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 1 views

Efficacy of ondansetron in the treatment

Efficacy of ondansetron in the treatment of generalized anxiety disorder

✍ A. M. Freeman III; J. R. Westphal; G. T. Norris; B. A. Roggero; P. B. Webb; K. L 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 1 views

Ondansetron is a highly selective antagonist at the 5-HT 3 subtype of serotonin (5-HT) receptors . The 5-HT 3 receptors are the only receptors whose effects are mediated through the ion channels rather than the G-protein series . Ondansetron has no appreciable affinity for other 5-HT receptor subtyp